Contact Us

DESTINATION NEWS

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor - licenced to Norgine for commercialisation in Europe.

Jan 26, 2025

LONDON,Jan. 25,2025-- Following the licensing agreement with X4 Pharmaceuticals,Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavor

Nisun International Announces Preliminary 2024 Financial Guidance and Strategic Business Updates

Jan 26, 2025

Company Anticipates Return to Growth in 2025 SHANGHAI,Jan. 24,2025-- Nisun International Enterprise Development Group Co.,Ltd ("Nisun International" or the "Company") (Nasdaq: NISN

Grant of Restricted Shares Under Big Tree Cloud Holdings Limited 2024 Equity Incentive Plan

Jan 26, 2025

SHENZHEN,China,Jan. 25,2025--Big Tree Cloud Holdings Limited ("Big Tree Cloud" or the "Company") (NASDAQ: DSY) (NASDAQ: DSYWW),a company devoted to the development,production,and s

Winter Davos 2025: Yidu Tech Accelerates Global Expansion of AI-Powered Healthcare Solutions

Jan 26, 2025

DAVOS,Switzerland,Jan. 24,2025--From January 20 to 24,the World Economic Forum Annual Meeting 2025,also known as Winter Davos,gathered global leaders in Davos,Switzerland. Representing China\'s AI-pow

Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors

Jan 26, 2025

SINGAPORE and PHILADELPHIA,Jan. 24,2025-- Nuevocor,an IND-stage biotechnology company dedicated to developing functional cures to treat cardiomyopathies with aberrant mechanobiology,today announces t

Global Focus on Chinese New Year: "Show Off Your Skills at Home During the Festival" Campaign Ignites a Chinese Cuisine Craze

Jan 22, 2025

1 ... 139 140 141 142 143 144 145 ... 376